Miao Ruan

Shanghai Jiao Tong University — China

Biochemistry, Genetics and Molecular Biology · Life Sciences

6h-index499citations17works2.32yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

DNA Repair Mechanisms(6), Cancer Immunotherapy and Biomarkers(5), PARP inhibition in cancer therapy(5), Cancer Cells and Metastasis(4), Lymphoma Diagnosis and Treatment(3)

Publications17 total

Clinicopathological, Genomic, and Transcriptomic Feature Analysis of Primary Adrenal Large B-cell Lymphoma
The American Journal of Surgical Pathology·2025· 1 citedOpen Access
485 Applications of the Mixture-of-Experts Foundational Model in Clinical Pathology Education
Laboratory Investigation·2025Open Access
1347 Boosting Prognosis Analysis of Patients with Diffuse Large B-cell Lymphoma through the Spatial Multi-modal Analysis Framework
Laboratory Investigation·2025Open Access
PD-L1 expression and tumor-infiltrating lymphocytes: Correlations and prognostic values in Chinese triple-negative breast cancer patients with different molecular subtyping
Pathology - Research and Practice·2024· 3 cited
Association between homologous recombination deficiency status and carboplatin treatment response in early triple-negative breast cancer
Breast Cancer Research and Treatment·2024· 8 citedOpen Access
Association of tumor immune infiltration and prognosis with homologous recombination repair genes mutations in early triple-negative breast cancer
Frontiers in Immunology·2024· 4 citedOpen Access
Primary large B-cell lymphoma of the adrenal gland has similar clinical, pathological, and genetic features to the primary large B-cell lymphoma of immune-privileged sites
Research Square (Research Square)·2024Open Access
The genetic landscape of histologically transformed marginal zone lymphomas
Cancer·2023· 11 citedOpen Access
Altered cytokeratin 5 expression in breast lobular myoepithelial cells
Journal of Clinical Pathology·2023· 1 cited
Mutation Spectrum of Homologous Recombination Repair Genes and Other Cancer Predisposition Genes in Early Triple-Negative Breast Cancer Association with Clinicopathological Factors, Immune Infiltration, and Prognosis
SSRN Electronic Journal·2023Open Access
Mutation Spectrum of Homologous Recombination Repair Genes in Early Triple-Negative Breast Cancer: Association with Clinicopathological Factors, Immune Infiltration, and Prognosis
SSRN Electronic Journal·2023Open Access
Associaction between Prognosis, Carboplatin Treatmene Response and Homologous Recombination Deficiency Status in Early Triple-Negative Breast Cancer
SSRN Electronic Journal·2023Open Access
Multi-Omics Profiling Reveals Distinct Microenvironment Characterization and Suggests Immune Escape Mechanisms of Triple-Negative Breast Cancer
Clinical Cancer Research·2019· 358 citedOpen Access
Predictive value of tumor-infiltrating lymphocytes to pathological complete response in neoadjuvant treated triple-negative breast cancers
Diagnostic Pathology·2018· 47 citedOpen Access
Expression of DNA Damage Response Proteins and Associations with Clinicopathologic Characteristics in Chinese Familial Breast Cancer Patients with <i>BRCA1/2</i> Mutations
Journal of Breast Cancer·2018· 5 citedOpen Access
Mixed invasive ductal and lobular carcinoma has distinct clinical features and predicts worse prognosis when stratified by estrogen receptor status
Scientific Reports·2017· 29 citedOpen Access
Evaluation of the prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers
Oncotarget·2016· 32 citedOpen Access

Frequent Co-authors

Chaofu Wang(8), Wentao Yang(5), Anqi Li(5), Hongmei Yi(5), Zheng Wang(5), Yujie Lu(5), Mengyuan Han(5), Changbin Zhu(5), Kunwei Shen(5), Xiaosong Chen(5), Shijie Deng(4), Haimin Xu(4), Lei Dong(4), Qian Da(4), Tian Tian(3), Ruohong Shui(3), Xia Shen(3), Zhongyu Wang(3), Lingyan Zhu(3), Zebing Liu(3)